Literature DB >> 7903269

South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.

J C Defesche1, D E van Diermen, P J Lansberg, R J Lamping, P W Reymer, M R Hayden, J J Kastelein.   

Abstract

In South African Afrikaners, three point mutations in the gene coding for the low-density lipoprotein (LDL)-receptor are responsible for more than 95% of the cases of familial hypercholesterolemia (FH). To investigate whether one or more of these mutations originated in The Netherlands, a large group of Dutch heterozygous FH patients was screened for the presence of these three mutations. Of these, a missense mutation in exon 9 of the LDL-receptor gene, resulting in a substitution of Met for Val408, responsible for 15% of FH in Afrikaners, was found in 19 (1.5%) of 1268 FH patients of Dutch descent. Nine of the patients carrying the exon 9 mutation on one allele shared the LDL-receptor DNA haplotype with an FH patient from South Africa, who was homozygous for the same mutation. This would suggest that the mutation in these patients and in the South African patient have a common ancestral background. The remaining ten FH patients all shared a common haplotype, partly identical to the Afrikaner haplotype, which could have arisen from a single recombinational event. This mutation has not been described in persons other than of Dutch ancestry and supports the hypothesis that this mutation in exon 9 originated in The Netherlands and, in all likelihood, was introduced into South Africa by early Dutch settlers in the seventeenth century.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903269     DOI: 10.1007/bf00420940

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community.

Authors:  K Steyn; M J Weight; B R Dando; K J Christopher; J E Rossouw
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolaemia.

Authors:  M J Kotze; E Langenhoven; L Warnich; L du Plessis; M P Marx; C J Oosthuizen; A E Retief
Journal:  S Afr Med J       Date:  1989-10-21

4.  Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients.

Authors:  A K Khachadurian; S M Uthman
Journal:  Nutr Metab       Date:  1973       Impact factor: 4.169

5.  Genetic linkage of hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease) to markers of chromosomes 1 and 17.

Authors:  J C Defesche; J E Hoogendijk; M de Visser; O de Visser; P A Bolhuis
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

6.  Polymorphic DNA haplotypes at the LDL receptor locus.

Authors:  E Leitersdorf; A Chakravarti; H H Hobbs
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

7.  The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners.

Authors:  M J Kotze; E Langenhoven; L Warnich; L du Plessis; A E Retief
Journal:  Ann Hum Genet       Date:  1991-05       Impact factor: 1.670

8.  Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia.

Authors:  M Jeenah; W September; F Graadt van Roggen; W de Villiers; H Seftel; D Marais
Journal:  Atherosclerosis       Date:  1993-01-04       Impact factor: 5.162

9.  A host of hypercholesterolaemic homozygotes in South Africa.

Authors:  H C Seftel; S G Baker; M P Sandler; M B Forman; B I Joffe; D Mendelsohn; T Jenkins; C J Mieny
Journal:  Br Med J       Date:  1980-09-06

Review 10.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Authors:  H H Hobbs; M S Brown; J L Goldstein
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

View more
  8 in total

1.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

Authors:  E J Sijbrands; R G Westendorp; J C Defesche; P H de Meier; A H Smelt; J J Kastelein
Journal:  BMJ       Date:  2001-04-28

2.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  Mutations in the low-density-lipoprotein receptor gene in German patients with familial hypercholesterolaemia.

Authors:  N Weiss; G Binder; C Keller
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

Review 4.  Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population.

Authors:  Khalid Al-Rasadi; Khalid Al-Waili; Hilal Ali Al-Sabti; Ali Al-Hinai; Khamis Al-Hashmi; Ibrahim Al-Zakwani; Yajnavalka Banerjee
Journal:  Oman Med J       Date:  2014-03

5.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.

Authors:  D Bhatnagar; J Morgan; S Siddiq; M I Mackness; J P Miller; P N Durrington
Journal:  BMJ       Date:  2000-12-16

6.  Screening for mutations in exon 4 of the LDL receptor gene: identification of a new deletion mutation.

Authors:  L Theart; M J Kotze; E Langenhoven; O Loubser; A V Peeters; C J Lintott; R S Scott
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

7.  Simultaneous detection of multiple familial hypercholesterolemia mutations facilitates an improved diagnostic service in South african patients at high risk of cardiovascular disease.

Authors:  Maritha J Kotze; Gernot Kriegshäuser; Rochelle Thiart; Nico J P de Villiers; Charlotte L Scholtz; Fritz Kury; Anne Moritz; Christian Oberkanins
Journal:  Mol Diagn       Date:  2003

8.  Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes.

Authors:  D M Kusters; R Huijgen; J C Defesche; M N Vissers; I Kindt; B A Hutten; J J P Kastelein
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.